stockrowUnited Therapeutics Corporation (UTHR) vs Viatris Inc. (VTRS)
- United Therapeutics Corporation UTHR 564.88 −7.17%
- Viatris Inc. VTRS 18.89 −1.72%
United Therapeutics Corporation and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. United Therapeutics Corporation is the larger, with a market value of $24.3B against $21.8B — 1.1× the size. Viatris Inc. has negative trailing earnings, so its P/E is not meaningful; United Therapeutics Corporation trades at 19.7×. Viatris Inc. grew revenue faster over the last twelve months: 4.27% against 1.89%. United Therapeutics Corporation has the higher net margin (38.6% vs −4.13%) and the higher return on invested capital (30.1% vs −0.02%). Across the 21 metrics below, United Therapeutics Corporation leads on 14 and Viatris Inc. on 7.
Valuation
Profitability
| Metric | UTHR | VTRS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 86.34% | 35.31% | 53.51% |
| Operating margin | 41.45% | (0.03%) | 0.00% |
| Net margin | 38.61% | (4.13%) | (2.45%) |
| Free cash flow margin | 27.21% | 16.27% | 0.00% |
| Return on equity | 19.13% | (4.21%) | (0.80%) |
| Return on assets | 17.11% | (1.67%) | (1.67%) |
| Return on invested capital | 30.13% | (0.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack